Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
about
Combating Tuberculosis Infection: A Forbidding ChallengeTargeting kinase signaling pathways with constrained peptide scaffolds.Polymeric nanoparticles for pulmonary protein and DNA delivery.Association between calcitonin receptor AluI gene polymorphism and bone mineral density: A meta-analysis.NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?Liposomes as drug delivery systems for the treatment of TB.Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.The effects of engineered nanoparticles on pulmonary immune homeostasis.Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption.Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunitiesPolymeric nanoparticles in development for treatment of pulmonary infectious diseases.Glucose-sensitive polymer nanoparticles for self-regulated drug delivery.Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.Pharmacological and toxicological assessment of innovative self-assembled polymeric micelles as powders for insulin pulmonary delivery.
P2860
Q26750683-78B828F6-D9F5-4145-BEDD-6EC39F57F4B9Q30398451-F8DB1CB2-DD21-449B-96CC-D2895B60B6B1Q33560960-5D9B2A46-FDBD-4FEF-9F47-A3A90BC3DF89Q34585379-6B445FBA-795A-4260-95CA-41108143C71AQ35977261-CA2BB1C3-D08F-4CD7-A580-BC875831F411Q37949386-F58BDB4B-47CC-41EF-8E34-450FDA9AD989Q38033610-2E31D7A9-09AF-4985-89C0-639FAC261AFFQ38165210-4BB980DC-C7E9-49DB-B8C9-14FAA7CF012EQ38168594-EE53B9BE-F686-467F-A5F1-911928F50975Q38787324-64A3523D-F4A4-4929-B1E4-1A3E8C17C1A1Q38789348-69B98551-4504-42F0-874D-A6550CF7E04BQ38837883-BB9202ED-3B19-43A4-81A5-6C67D3DDE1F0Q38847705-2001A1AE-F6D6-4D80-AB10-D0FB7048C197Q41931571-DA730A7D-21C2-45F1-A52A-1F1B584492A6Q51596702-4B1130DD-950F-4CA3-A1E2-45235808B05C
P2860
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@en
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@nl
type
label
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@en
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@nl
prefLabel
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@en
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@nl
P2860
P50
P356
P1433
P1476
Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
@en
P2860
P304
P356
10.2217/NNM.10.143
P577
2011-01-01T00:00:00Z